Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In this double-blind, randomized, placebo-controlled, single-center trial, 280 patients with Morbus Parkinson / Parkinson's Disease (PD) were screened, and 72 eligible patients were block-randomized (1:1) to receive either multistrain probiotics capsules (n = 34) or identical-appearing placebo (n = 38), for 4 weeks.
Primary outcome measures:
Change in frequency of bowel opening per week
Classification of evidence: This study provides Class I evidence that, for people with Morbus Parkinson / Parkinson's Disease (PD), multistrain probiotics significantly increased the average number of SBM per week.
The authors' conclusion was: Multistrain probiotics treatment was effective for constipation in Morbus Parkinson / Parkinson's Disease (PD). Further studies are needed to investigate the long-term efficacy and s…